GUASTAMACCHIA, Giulia
GUASTAMACCHIA, Giulia
Dip. NEUROSCIENZE (attivo dal 01/01/1900 al 30/04/2013)
Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIV
2023-01-01 Trunfio, Mattia; Mighetto, Lorenzo; Napoli, Laura; Atzori, Cristiana; Nigra, Marco; Guastamacchia, Giulia; Bonora, Stefano; Di Perri, Giovanni; Calcagno, Andrea
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders
2022-01-01 Barco, A; Orlando, S; Stroffolini, G; Pirriatore, V; Lazzaro, A; Vai, D; Guastamacchia, G; Noce, G; Atzori, C; Trunfio, M; Bonora, S; Di Perri, G; Calcagno, A
Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV
2020-01-01 Trunfio, Mattia; Rugge, Walter; Mighetto, Lorenzo; Vai, Daniela; Atzori, Cristiana; Nigra, Marco; Domini, Simone; Borgogno, Enrica; Guastamacchia, Giulia; Bonora, Stefano; Di Perri, Giovanni; Calcagno, Andrea
Full reservoirs and poor adherence: two cases of symptomatic HIV cerebrospinal fluid escape with tenofovir alafenamide/emtricitabine/bictegravir
2025-01-01 Calcagno, Andrea; Lipani, Carola; Rizzello, Barbara; Mussa, Marco; Perinzano, Andrea; Angilletta, Roberto; Romano, Francesca; Bosio, Roberta; Allice, Tiziano; Calitri, Carmelina; Guastamacchia, Giulia; Trunfio, Mattia; Di Perri, Giovanni; Bonora, Stefano
Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
2021-01-01 Stroffolini G.; Guastamacchia G.; Audagnotto S.; Atzori C.; Trunfio M.; Nigra M.; Di Stefano A.; Di Perri G.; Calcagno A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIV | 2023 | Trunfio, Mattia; Mighetto, Lorenzo; Napoli, Laura; Atzori, Cristiana; Nigra, Marco; Guastamacchia, Giulia; Bonora, Stefano; Di Perri, Giovanni; Calcagno, Andrea | |
| Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders | 2022 | Barco, A; Orlando, S; Stroffolini, G; Pirriatore, V; Lazzaro, A; Vai, D; Guastamacchia, G; Noce, G; Atzori, C; Trunfio, M; Bonora, S; Di Perri, G; Calcagno, A | |
| Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV | 2020 | Trunfio, Mattia; Rugge, Walter; Mighetto, Lorenzo; Vai, Daniela; Atzori, Cristiana; Nigra, Marco; Domini, Simone; Borgogno, Enrica; Guastamacchia, Giulia; Bonora, Stefano; Di Perri, Giovanni; Calcagno, Andrea | |
| Full reservoirs and poor adherence: two cases of symptomatic HIV cerebrospinal fluid escape with tenofovir alafenamide/emtricitabine/bictegravir | 2025 | Calcagno, Andrea; Lipani, Carola; Rizzello, Barbara; Mussa, Marco; Perinzano, Andrea; Angilletta, Roberto; Romano, Francesca; Bosio, Roberta; Allice, Tiziano; Calitri, Carmelina; Guastamacchia, Giulia; Trunfio, Mattia; Di Perri, Giovanni; Bonora, Stefano | |
| Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis | 2021 | Stroffolini G.; Guastamacchia G.; Audagnotto S.; Atzori C.; Trunfio M.; Nigra M.; Di Stefano A.; Di Perri G.; Calcagno A. |